Literature DB >> 16699057

Fatal exacerbation of fibrosing alveolitis associated with systemic sclerosis in a patient treated with adalimumab.

Y Allanore, G Devos-François, C Caramella, P Boumier, V Jounieaux, A Kahan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16699057      PMCID： PMC1798181          DOI： 10.1136/ard.2005.044453

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

1.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

Authors:  E C LeRoy; C Black; R Fleischmajer; S Jablonska; T Krieg; T A Medsger; N Rowell; F Wollheim
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

2.  Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximab.

Authors:  Andrew J K Ostor; Adrian J Crisp; Margaret F Somerville; David G I Scott
Journal:  BMJ       Date:  2004-11-27

3.  Antagonistic effects of TNF-alpha on TGF-beta signaling through down-regulation of TGF-beta receptor type II in human dermal fibroblasts.

Authors:  Kenichi Yamane; Hironobu Ihn; Yoshihide Asano; Masatoshi Jinnin; Kunihiko Tamaki
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

4.  Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.

Authors:  Carlo Chizzolini; Yann Parel; Carmelina De Luca; Alan Tyndall; Anita Akesson; Agneta Scheja; Jean-Michel Dayer
Journal:  Arthritis Rheum       Date:  2003-09

5.  Elevated expression of the genes encoding TNF-alpha and thromboxane synthase in leucocytes from patients with systemic sclerosis.

Authors:  V Young; M Ho; H Vosper; J J F Belch; C N A Palmer
Journal:  Rheumatology (Oxford)       Date:  2002-08       Impact factor: 7.580
  5 in total
  13 in total

Review 1.  Immunotherapy of systemic sclerosis.

Authors:  Rebecca Manno; Francesco Boin
Journal:  Immunotherapy       Date:  2010-11       Impact factor: 4.196

Review 2.  [Clinical risk-adapted therapies in systemic sclerosis].

Authors:  G Riemekasten; D Dragun
Journal:  Z Rheumatol       Date:  2007-12       Impact factor: 1.372

3.  [Towards an implementation of guidelines for the therapy of systemic sclerosis (scleroderma): between desire and reality].

Authors:  M O Becker; U Müller-Ladner; G Riemekasten
Journal:  Z Rheumatol       Date:  2010-06       Impact factor: 1.372

Review 4.  Inflammatory arthritis in systemic sclerosis: What to do?

Authors:  Rebecca B Blank; Ogonna Kenechi Nwawka; Anna A Yusov; Jessica K Gordon
Journal:  J Scleroderma Relat Disord       Date:  2018-06-19

5.  Twist1 in T Lymphocytes Augments Kidney Fibrosis after Ureteral Obstruction.

Authors:  Jiafa Ren; Xiaohan Lu; Robert Griffiths; Jamie R Privratsky; Steven D Crowley
Journal:  Kidney360       Date:  2021-03-18

Review 6.  Is biological therapy in systemic sclerosis the answer?

Authors:  Durga Prasanna Misra; Sakir Ahmed; Vikas Agarwal
Journal:  Rheumatol Int       Date:  2020-01-20       Impact factor: 2.631

7.  Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Robert P Baughman; Keith C Meyer; Ian Nathanson; Luis Angel; Sangeeta M Bhorade; Kevin M Chan; Daniel Culver; Christopher G Harrod; Mary S Hayney; Kristen B Highland; Andrew H Limper; Herbert Patrick; Charlie Strange; Timothy Whelan
Journal:  Chest       Date:  2012-11       Impact factor: 9.410

8.  Intravenous immunoglobulins improve the function and ameliorate joint involvement in systemic sclerosis: a pilot study.

Authors:  F Nacci; A Righi; M L Conforti; I Miniati; G Fiori; D Martinovic; D Melchiorre; T Sapir; M Blank; Y Shoenfeld; A Moggi Pignone; M Matucci Cerinic
Journal:  Ann Rheum Dis       Date:  2007-03-07       Impact factor: 19.103

Review 9.  Animal models of systemic sclerosis: their utility and limitations.

Authors:  Carol M Artlett
Journal:  Open Access Rheumatol       Date:  2014-07-01

10.  Adalimumab-induced acute interstitial lung disease in a patient with rheumatoid arthritis.

Authors:  Olívia Meira Dias; Daniel Antunes Silva Pereira; Bruno Guedes Baldi; André Nathan Costa; Rodrigo Abensur Athanazio; Ronaldo Adib Kairalla; Carlos Roberto Ribeiro Carvalho
Journal:  J Bras Pneumol       Date:  2014 Jan-Feb       Impact factor: 2.624
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.